Predictors of Early and Late Response to Esomezol and Lifestyle Modification in Adults With Laryngopharyngeal Reflux Disease: A Prospective, Multicenter, Open-Label Cohort Study

Objectives This study aimed to assess predictors of the response to varying durations of proton pump inhibitor (PPI) use and lifestyle modification treatment for laryngopharyngeal reflux disease (LPRD). Methods Between October 2014 and June 2016, a prospective, multicenter, open-label, single-cohort...

Full description

Bibliographic Details
Main Authors: Seong Keun Kwon, Sung Joon Park, Eun-Jae Chung, Jin-Ho Sohn, Dong-Il Sun, Sung Min Jin, Byung-Joo Lee, Il-Seok Park, Jae-Gu Cho, Young Hak Park
Format: Article
Language:English
Published: Korean Society of Otorhinolaryngology-Head and Neck Surgery 2023-08-01
Series:Clinical and Experimental Otorhinolaryngology
Subjects:
Online Access:http://www.e-ceo.org/upload/pdf/ceo-2023-00409.pdf
_version_ 1827856357745754112
author Seong Keun Kwon
Sung Joon Park
Eun-Jae Chung
Jin-Ho Sohn
Dong-Il Sun
Sung Min Jin
Byung-Joo Lee
Il-Seok Park
Jae-Gu Cho
Young Hak Park
author_facet Seong Keun Kwon
Sung Joon Park
Eun-Jae Chung
Jin-Ho Sohn
Dong-Il Sun
Sung Min Jin
Byung-Joo Lee
Il-Seok Park
Jae-Gu Cho
Young Hak Park
author_sort Seong Keun Kwon
collection DOAJ
description Objectives This study aimed to assess predictors of the response to varying durations of proton pump inhibitor (PPI) use and lifestyle modification treatment for laryngopharyngeal reflux disease (LPRD). Methods Between October 2014 and June 2016, a prospective, multicenter, open-label, single-cohort, intention-to-treat, observational study was conducted at eight referral hospitals across the Republic of Korea to examine predictors of early and late response to treatment in adult patients (age ≥19 years) with LPRD. Participants underwent standard treatment (PPI [Esomezol] and lifestyle modification) for 3 months. Response to treatment was defined as greater than 50% improvement in reflux symptom index score. The primary outcome was potential predictors of treatment response at 1 and 3 months. The secondary outcome was potential predictors distinguishing early from late responders. Results In total, 394 patients were enrolled. Improved sleep habits was a positive predictor (odds ratio [OR], 1.785; 95% confidence interval [CI], 1.06–3.007; P=0.029), while initial alcohol consumption (OR, 0.587; 95% CI, 0.355–0.969; P=0.037) and past medication history (OR, 0.438; 95% CI, 0.215–0.891; P=0.005) were negative predictors of response after 1 month of treatment. High pre-reflux finding score was a positive predictor (OR, 1.187; 95% CI, 1.049– 1.344; P=0.007), while male sex (OR, 0.516; 95% CI, 0.269–0.987; P=0.046), higher depression score (OR, 0.867; 95% CI, 0.784–0.958; P=0.005), and past thyroid hormone medication history (OR, 0.161; 95% CI, 0.033–0.788; P=0.024) were negative predictors of response after 3 months of treatment. Past medication history (OR, 0.438; 95% CI, 0.215–0.891; P=0.023) was the only negative predictor for early responders compared to late responders. Conclusion Adult patients with LPRD and a history of prior medication use may require longer treatment durations to achieve a therapeutic response. Future research should explore the incorporation of diverse treatment approaches to improve treatment outcomes for patients exhibiting negative prognostic indicators.
first_indexed 2024-03-12T12:23:36Z
format Article
id doaj.art-55f7730aa0e64ae99524b91fb232060e
institution Directory Open Access Journal
issn 1976-8710
2005-0720
language English
last_indexed 2024-03-12T12:23:36Z
publishDate 2023-08-01
publisher Korean Society of Otorhinolaryngology-Head and Neck Surgery
record_format Article
series Clinical and Experimental Otorhinolaryngology
spelling doaj.art-55f7730aa0e64ae99524b91fb232060e2023-08-30T04:39:42ZengKorean Society of Otorhinolaryngology-Head and Neck SurgeryClinical and Experimental Otorhinolaryngology1976-87102005-07202023-08-0116325927410.21053/ceo.2023.00409866Predictors of Early and Late Response to Esomezol and Lifestyle Modification in Adults With Laryngopharyngeal Reflux Disease: A Prospective, Multicenter, Open-Label Cohort StudySeong Keun Kwon0Sung Joon Park1Eun-Jae Chung2Jin-Ho Sohn3Dong-Il Sun4Sung Min Jin5Byung-Joo Lee6Il-Seok Park7Jae-Gu Cho8Young Hak Park9 Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea Department of Otorhinolaryngology-Head and Neck Surgery, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Korea Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea Department of Otolaryngology-Head and Neck Surgery, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Korea Department of Otorhinolaryngology-Head and Neck Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Department of Otorhinolaryngology-Head and Neck Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea Department of Otorhinolaryngology-Head and Neck Surgery, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea Department of Otorhinolaryngology-Head and Neck Surgery, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Suwon, Korea Department of Otorhinolaryngology-Head and Neck Surgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea Department of Otorhinolaryngology-Head and Neck Surgery, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, KoreaObjectives This study aimed to assess predictors of the response to varying durations of proton pump inhibitor (PPI) use and lifestyle modification treatment for laryngopharyngeal reflux disease (LPRD). Methods Between October 2014 and June 2016, a prospective, multicenter, open-label, single-cohort, intention-to-treat, observational study was conducted at eight referral hospitals across the Republic of Korea to examine predictors of early and late response to treatment in adult patients (age ≥19 years) with LPRD. Participants underwent standard treatment (PPI [Esomezol] and lifestyle modification) for 3 months. Response to treatment was defined as greater than 50% improvement in reflux symptom index score. The primary outcome was potential predictors of treatment response at 1 and 3 months. The secondary outcome was potential predictors distinguishing early from late responders. Results In total, 394 patients were enrolled. Improved sleep habits was a positive predictor (odds ratio [OR], 1.785; 95% confidence interval [CI], 1.06–3.007; P=0.029), while initial alcohol consumption (OR, 0.587; 95% CI, 0.355–0.969; P=0.037) and past medication history (OR, 0.438; 95% CI, 0.215–0.891; P=0.005) were negative predictors of response after 1 month of treatment. High pre-reflux finding score was a positive predictor (OR, 1.187; 95% CI, 1.049– 1.344; P=0.007), while male sex (OR, 0.516; 95% CI, 0.269–0.987; P=0.046), higher depression score (OR, 0.867; 95% CI, 0.784–0.958; P=0.005), and past thyroid hormone medication history (OR, 0.161; 95% CI, 0.033–0.788; P=0.024) were negative predictors of response after 3 months of treatment. Past medication history (OR, 0.438; 95% CI, 0.215–0.891; P=0.023) was the only negative predictor for early responders compared to late responders. Conclusion Adult patients with LPRD and a history of prior medication use may require longer treatment durations to achieve a therapeutic response. Future research should explore the incorporation of diverse treatment approaches to improve treatment outcomes for patients exhibiting negative prognostic indicators.http://www.e-ceo.org/upload/pdf/ceo-2023-00409.pdflaryngopharyngeal refluxproton pump inhibitorslife style modificationpredictive factorpatient compliancepatient medical historymedication history
spellingShingle Seong Keun Kwon
Sung Joon Park
Eun-Jae Chung
Jin-Ho Sohn
Dong-Il Sun
Sung Min Jin
Byung-Joo Lee
Il-Seok Park
Jae-Gu Cho
Young Hak Park
Predictors of Early and Late Response to Esomezol and Lifestyle Modification in Adults With Laryngopharyngeal Reflux Disease: A Prospective, Multicenter, Open-Label Cohort Study
Clinical and Experimental Otorhinolaryngology
laryngopharyngeal reflux
proton pump inhibitors
life style modification
predictive factor
patient compliance
patient medical history
medication history
title Predictors of Early and Late Response to Esomezol and Lifestyle Modification in Adults With Laryngopharyngeal Reflux Disease: A Prospective, Multicenter, Open-Label Cohort Study
title_full Predictors of Early and Late Response to Esomezol and Lifestyle Modification in Adults With Laryngopharyngeal Reflux Disease: A Prospective, Multicenter, Open-Label Cohort Study
title_fullStr Predictors of Early and Late Response to Esomezol and Lifestyle Modification in Adults With Laryngopharyngeal Reflux Disease: A Prospective, Multicenter, Open-Label Cohort Study
title_full_unstemmed Predictors of Early and Late Response to Esomezol and Lifestyle Modification in Adults With Laryngopharyngeal Reflux Disease: A Prospective, Multicenter, Open-Label Cohort Study
title_short Predictors of Early and Late Response to Esomezol and Lifestyle Modification in Adults With Laryngopharyngeal Reflux Disease: A Prospective, Multicenter, Open-Label Cohort Study
title_sort predictors of early and late response to esomezol and lifestyle modification in adults with laryngopharyngeal reflux disease a prospective multicenter open label cohort study
topic laryngopharyngeal reflux
proton pump inhibitors
life style modification
predictive factor
patient compliance
patient medical history
medication history
url http://www.e-ceo.org/upload/pdf/ceo-2023-00409.pdf
work_keys_str_mv AT seongkeunkwon predictorsofearlyandlateresponsetoesomezolandlifestylemodificationinadultswithlaryngopharyngealrefluxdiseaseaprospectivemulticenteropenlabelcohortstudy
AT sungjoonpark predictorsofearlyandlateresponsetoesomezolandlifestylemodificationinadultswithlaryngopharyngealrefluxdiseaseaprospectivemulticenteropenlabelcohortstudy
AT eunjaechung predictorsofearlyandlateresponsetoesomezolandlifestylemodificationinadultswithlaryngopharyngealrefluxdiseaseaprospectivemulticenteropenlabelcohortstudy
AT jinhosohn predictorsofearlyandlateresponsetoesomezolandlifestylemodificationinadultswithlaryngopharyngealrefluxdiseaseaprospectivemulticenteropenlabelcohortstudy
AT dongilsun predictorsofearlyandlateresponsetoesomezolandlifestylemodificationinadultswithlaryngopharyngealrefluxdiseaseaprospectivemulticenteropenlabelcohortstudy
AT sungminjin predictorsofearlyandlateresponsetoesomezolandlifestylemodificationinadultswithlaryngopharyngealrefluxdiseaseaprospectivemulticenteropenlabelcohortstudy
AT byungjoolee predictorsofearlyandlateresponsetoesomezolandlifestylemodificationinadultswithlaryngopharyngealrefluxdiseaseaprospectivemulticenteropenlabelcohortstudy
AT ilseokpark predictorsofearlyandlateresponsetoesomezolandlifestylemodificationinadultswithlaryngopharyngealrefluxdiseaseaprospectivemulticenteropenlabelcohortstudy
AT jaegucho predictorsofearlyandlateresponsetoesomezolandlifestylemodificationinadultswithlaryngopharyngealrefluxdiseaseaprospectivemulticenteropenlabelcohortstudy
AT younghakpark predictorsofearlyandlateresponsetoesomezolandlifestylemodificationinadultswithlaryngopharyngealrefluxdiseaseaprospectivemulticenteropenlabelcohortstudy